Vasopressin-Adrenergic Interaction in Heart Failure

Stone, Charles K.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Heart, Lung, and Blood Institute (NHLBI)
• Type: Postdoctoral Individual National Research Service Award (F32)
• Project #: 5F32HL007445-02
• Application #: 3050281
• Study Section: (BI)
• Project Start: 1987-07-01
• Budget Start: 1987-07-01
• Budget End: 1988-06-30
• Support Year: 2
• Fiscal Year: 1987

Institution

• Name: University of Rochester
• Type: School of Medicine & Dentistry
• DUNS #: 208469486
• City: Rochester
• State: NY
• Country: United States
• Zip Code: 14627

Publications

Fan, T H; Frantz, R P; Elam, H et al. (1993) Reductions of myocardial Na-K-ATPase activity and ouabain binding sites in heart failure: prevention by nadolol. Am J Physiol 265:H2086-93

Sakamoto, S; Stone, C K; Woolf, P D et al. (1989) Opiate receptor antagonism in right-sided congestive heart failure. Naloxone exerts salutary hemodynamic effects through its action on the central nervous system. Circ Res 65:103-14

Stone, C K; Liang, C S; Imai, N et al. (1988) Short-term hemodynamic effects of vasopressin V1-receptor inhibition in chronic right-sided congestive heart failure. Circulation 78:1251-9